NO151119C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive ornithin og argininsalter av forgrenede ketosyrer - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive ornithin og argininsalter av forgrenede ketosyrer

Info

Publication number
NO151119C
NO151119C NO790903A NO790903A NO151119C NO 151119 C NO151119 C NO 151119C NO 790903 A NO790903 A NO 790903A NO 790903 A NO790903 A NO 790903A NO 151119 C NO151119 C NO 151119C
Authority
NO
Norway
Prior art keywords
ketos
arginal
ornithin
branched
salts
Prior art date
Application number
NO790903A
Other languages
English (en)
Norwegian (no)
Other versions
NO790903L (no
NO151119B (no
Inventor
Mackenzie M D Walser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of NO790903L publication Critical patent/NO790903L/no
Publication of NO151119B publication Critical patent/NO151119B/no
Publication of NO151119C publication Critical patent/NO151119C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO790903A 1978-03-17 1979-03-16 Analogifremgangsmaate ved fremstilling av terapeutisk aktive ornithin og argininsalter av forgrenede ketosyrer NO151119C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Publications (3)

Publication Number Publication Date
NO790903L NO790903L (no) 1979-09-18
NO151119B NO151119B (no) 1984-11-05
NO151119C true NO151119C (no) 1985-02-13

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790903A NO151119C (no) 1978-03-17 1979-03-16 Analogifremgangsmaate ved fremstilling av terapeutisk aktive ornithin og argininsalter av forgrenede ketosyrer

Country Status (17)

Country Link
US (1) US4228099A (fi)
JP (1) JPS5838421B2 (fi)
AU (1) AU517505B2 (fi)
BE (1) BE874900A (fi)
CA (1) CA1115729A (fi)
DE (1) DE2910221A1 (fi)
DK (1) DK153542C (fi)
ES (1) ES478710A1 (fi)
FI (1) FI72118C (fi)
FR (1) FR2419723A1 (fi)
GB (1) GB2017094B (fi)
IE (1) IE48336B1 (fi)
IT (1) IT1202904B (fi)
LU (1) LU81057A1 (fi)
NL (1) NL7902136A (fi)
NO (1) NO151119C (fi)
SE (1) SE446724B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
CN1136764A (zh) 1994-10-07 1996-11-27 弗门尼舍有限公司 风味组合物及其制备方法
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
JP2004527529A (ja) * 2001-04-04 2004-09-09 クリティカル セラピューティックス インコーポレイテッド 急性腎不全を予防するための方法
US7772280B2 (en) * 2004-11-15 2010-08-10 Kyowa Hakko Bio Co., Ltd. Crystals of L-ornithine and process for producing the same
SI2319581T1 (sl) * 2004-11-26 2015-10-30 Ucl Business Plc Pripravki, ki obsegajo ornitin in fenilacetat ali fenilbutirat za zdravljenje hepatične encefalopatije
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
NO2413924T3 (fi) 2009-04-03 2018-02-24
BRPI1012956A8 (pt) 2009-06-08 2021-11-03 Ocera Therapeutics Inc Usos da l-ornitina e de pelo menos um de fenilacetato e fenilbutirato
JP6087284B2 (ja) 2010-10-06 2017-03-01 オセラ セラピューティクス， インコーポレイテッド Ｌ−オルニチンフェニルアセテートを製造するための方法
CN107206021B (zh) 2014-11-24 2021-09-03 Ucl商业有限公司 使用降氨疗法治疗与肝星状细胞激活相关的疾病
AU2016308641B2 (en) 2015-08-18 2022-02-03 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (en) * 2015-11-29 2017-06-01 Rao M Surya Compositions and methods for the treatment of urea cycle disorders and hepatic diseases
AU2018266357B2 (en) 2017-05-11 2022-12-08 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
US11253496B2 (en) 2017-11-29 2022-02-22 Edgar L. Hull Alpha keto acid compositions for treating hypo-albuminemia
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100293A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
AU517505B2 (en) 1981-08-06
IE790993L (en) 1979-09-17
AU4515479A (en) 1979-09-20
GB2017094B (en) 1982-07-07
NO790903L (no) 1979-09-18
BE874900A (fr) 1979-07-16
SE7902401L (sv) 1979-10-16
FI790901A (fi) 1979-09-18
FI72118B (fi) 1986-12-31
ES478710A1 (es) 1980-01-16
DE2910221A1 (de) 1979-09-20
LU81057A1 (fr) 1979-09-07
FR2419723B1 (fi) 1982-10-29
CA1115729A (en) 1982-01-05
JPS54163518A (en) 1979-12-26
DK110879A (da) 1979-09-18
NL7902136A (nl) 1979-09-19
IT1202904B (it) 1989-02-15
DE2910221C2 (fi) 1988-04-28
SE446724B (sv) 1986-10-06
DK153542C (da) 1988-12-05
NO151119B (no) 1984-11-05
IE48336B1 (en) 1984-12-12
FR2419723A1 (fr) 1979-10-12
US4228099A (en) 1980-10-14
JPS5838421B2 (ja) 1983-08-23
FI72118C (fi) 1987-04-13
GB2017094A (en) 1979-10-03
IT7921071A0 (it) 1979-03-16
DK153542B (da) 1988-07-25

Similar Documents

Publication Publication Date Title
NO151119C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive ornithin og argininsalter av forgrenede ketosyrer
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151320C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO145236C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive omega-aminocarboxylsyrederivater
NO802087L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
NO152128C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO148452C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-fenyl-1-propanol-derivater